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Objective: It is unknown whether the decreasing prevalence of H. pylori infections is associated with the increase in
obesity and asthma and allergy. In this study, we assessed if obesity plays an intermediate role between H. pylori
infections and allergy.
Design: A population-based, nested case-control study of 10,005 participants within the second Nord-Trøndelag
Health Study (HUNT2), Norway, was performed in 1995–1997. The presence of H. pylori was tested by an enzyme
immunoassay Pyloriset EIA-IgG, and weight, height, and waist circumference were measured. Body mass index
(BMI) and waist circumference were used as measures of general and abdominal obesity, respectively. Self-
reported asthma and allergic diseases were collected through questionnaires. The odds ratios of H. pylori rela-
tive to asthma and allergic diseases were estimated by logistic regression models stratiﬁed by waist circumference
categories.
Results: H. pylori infection was present in 31%, ever asthma was reported in 10.4% and allergic rhinitis in 16.2%.
The mean BMI was 26.4 kg/m2 and the mean waist circumference was 86.6 cm. H. pylori infection was neither
associated with asthma nor allergic diseases. However, when stratiﬁed by waist circumference, H. pylori infection
was associated with 30–40% reduced odds of asthma and 25% reduced odds of allergic diseases in individuals
with abdominal obesity (waist circumference 86 cm in women and 96 cm in men).
Conclusion: H. pylori infection is associated with reduced risk of asthma and allergy in individuals with abdominal
obesity, suggesting a possible causal pathway from reduced H. pylori infections through obesity to increased risk
of asthma and allergy.Introduction
Infection withHelicobacter pylori (H. pylori) is common in humans and
associated with socioeconomic status and living conditions in child-
hood.1 In developed countries, the prevalence of H. pylori infections has
rapidly decreased in parallel to economic improvement over the past
decades.2 This might be due to improved hygiene and sanitation, less
salted food, and possibly increased use of antimicrobial agents.
Interestingly, as the prevalence of H. pylori has declined, there has
been a rise in the prevalence of asthma and allergic diseases (e.g., hay
fever and atopy) in developed countries.3–5 Tobacco smoking, airh, Susan and Henry Samueli Col
. Ness-Jensen), arnulf.langhamme
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vier Inc. on behalf of World Allepollution, allergens, microbial infection, and obesity are among the
potentially attributable exposures that may cause the increase of asthma
and allergic diseases.6,7 As an indigenous microbiota, the decrease of
H. pylori has been postulated to play a role in this increase.8 There have
been quite a few epidemiologic studies examining the association be-
tween H. pylori and asthma and allergic diseases. The results, however,
are largely controversial.9
Parallel to the decrease in H. pylori infections, there has been a global
increase of obesity during the past decades.10,11 Obesity is associated
with chronic inﬂammation which may be involved in the allergic
response.12 A positive association between obesity and asthma andlege of Health Sciences, University of California, Irvine, 653 E. Peltason Drive,
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of H. pylori infection has been associated with obesity in accumulating
studies.15,16 Thus, there could be an association between H. pylori,
obesity, and asthma and allergic diseases, but so far this has not been
studied. Whether lack of H. pylori infection leads to increased risk of
asthma and allergic diseases and obesity, independent of each other, or
the lack of H. pylori infection leads to increased obesity and then
increased risk of allergic diseases, as a part of the same causal pathway, is
unknown. In this large population-based Norwegian study, we examined
the association between H. pylori infection, obesity, and asthma and
allergic diseases.
Methods
Study design
In this nested case-control study, data from the second survey of the
Nord-Trøndelag Health Study (HUNT2) was used.17 In HUNT2, per-
formed in 1995–1997, all residents of Nord-Trøndelag County aged 20
years and older were invited to answer questionnaires and interviews,
participate in clinical examinations, and contribute with biological ma-
terial. Among 65,237 participants in HUNT2 (69.5% of invited), serum
from 10,005 randomly selected individuals were tested for H. pylori.
Study outcome
Asthma and allergy
Asthma and allergy were assessed through self-reported question-
naires in HUNT2. Asthma was deﬁned as present if the participants re-
ported to have or have had asthma (ever), or if they reported to use or
have used asthma medication (deﬁnition I). To avoid misclassiﬁcation
with chronic obstructive pulmonary disease (COPD) due to tobacco
smoking, we also deﬁned asthma as for deﬁnition I, but excluding par-
ticipants that had smoked for more than 10 years (deﬁnition II). The
participants also reported age of onset of asthma. Allergic rhinitis was
deﬁned as present if the participants reported to have hay fever or nasal
allergy.
Main exposures
H. pylori
Serological status of H. pylori IgG antibodies was analysed using the
commercially available enzyme immunoassay Pylorisert EIA-IgG (Orion
Diagnostica, Espoo, Finland) at Levanger Hospital, Norway. Assay for
detection of H. pylori was performed in 1998. The cut-off level used for a
positive H. pylori IgG was 300 U.18
General obesity and abdominal obesity
Trained personnel at the screening stations objectively measured
height, weight, and waist circumference during HUNT2. Bodymass index
(BMI) was calculated by dividing weight in kilograms by height in meters
squared (kg/m2) for estimation of general obesity. According to the
World Health Organization's deﬁnitions, obesity was deﬁned as BMI30
and abdominal obesity as waist circumference 86 cm in women and
96 cm in men.
Other factors
The following factors were selected a priori and included in the ana-
lyses: sex, age, tobacco smoking, alcohol drinking (monthly frequency of
drinking), physical activity (reported hours of physical activity [light and
hard] per week in the last year), highest completed education, and family
history of asthma and allergy. Except from sex and age, all factors were
assessed through self-reported questionnaires. Family history of asthma
or allergic rhinitis was reported on ﬁrst degree relatives (parents, sib-
lings, and children).2Statistical analysis
Logistic regression was used to assess odds ratios (ORs) and 95%
conﬁdence intervals (CIs) for the associations between H. pylori, obesity,
and asthma and allergy. Separate analyses were performed stratiﬁed for
waist circumference categories based on the sex-speciﬁc intervals: <75,
75 to <86, and 86 for women; and <88, 88 to <96, and 96 for
men. The fully adjusted analyses were performed with age as a contin-
uous variable, while the other variables were categorized. Tobacco
smoking was categorized as never, occasional, and daily. Alcohol
drinking was categorized as never, infrequent (once a week or less), and
frequent (more than once a week). Physical activity was categorized as
inactive (no activity or less than one hour light activity a week),
moderately active (1–2 hours light activity or less than 1 hour hard ac-
tivity a week), and highly active (at least 3 hours light activity or at least
1 hour hard activity a week). Completed education was categorized as
primary school, high school, and college/university. In order to entangle
the complex relations between H. pylori, obesity and asthma and al-
lergies, we performed a mediation analysis to estimate the indirect effect
of obesity relative to the total effect of H. pylori on the outcome of in-
terest. The SAS 9.4 for Window was applied for data management,
descriptive statistical analysis and logistic regression. All statistical
analysis were two sides with signiﬁcant level at 0.05.
Ethical approval
The study has ethical approval through the Regional Committee for
Medical and Health Research Ethics, Central Norway (2012/1878). In
HUNT, all participants gave written informed consent when partici-
pating, stating that their data could be used in future medical research.
Results
Characteristics
In the study population, the mean age was 50 years, 54% were
women, and 31% were H. pylori positive (Table 1). The mean BMI was
26.4 kg/m2 (men:26.4; women; 26.3, respectively) and the mean waist
circumference was 86.6 cm (men: 92.3; women: 81.6, respectively). Ever
having had asthma was reported by 10.4% and after excluding those
smoking >10 years, the ﬁgure was 5.7%. Hay fever or nasal allergies
were reported by 15.1% and allergic rhinitis (including use of anti-
allergy medication) were present in 16.2%. In total, 26.5% of the
10,005 participants had asthma or an allergic disease.
Associations
H. pylori infection was not associated with asthma or allergic diseases
in general (Table 2), neither using the basic model, adjusting for sex and
age, nor using the full model, also adjusting for BMI, tobacco smoking,
alcohol drinking, physical activity, education, and family history of
asthma and allergic diseases.
Effect modiﬁcation analysis
However, when stratifying for waist circumference,H. pylori infection
was associated with asthma and allergy in individuals with abdominal
obesity (waist circumference 86 cm in women and 96 cm in men)
(Table 3). In abdominal obesity, H. pylori infection was associated with a
40% reduced odds of asthma (deﬁnition I) with onset below 18 years of
age (fully adjusted OR 0.61, 95% CI 0.37–0.99). H. pylori infection in
abdominal obesity was not associated with asthma (deﬁnition I) with
onset above 18 years of age (fully adjusted OR 0.98, 95% CI 0.71–1.35).
Excluding those smoking for more than 10 years (deﬁnition II), H. pylori
infection in abdominal obesity was associated with a 30% reduced odds
of asthma (fully adjusted OR 0.70, 95% CI 0.50–0.97). H. pylori infection
Table 1
Basic characteristics of the randomly selected 10005 HUNT2 participants.
Total Asthma Hay fever or nasal allergies Allergic rhinitis Asthma or allergic rhinitis
Deﬁnition I Deﬁnition II
Total N % N % N % N % N % N %
10005 100 1041 10.40 569 5.69 1507 15.06 1620 16.19 2655 26.54
Sex
Women 5414 54.11 576 55.33 334 58.70 882 58.53 951 58.70 1488 56.05
Men 4591 45.89 465 44.67 235 41.30 625 41.47 669 41.30 1167 43.95
Age
Mean (SD) 50.11 (16.78) 50.11 (17.51) 46.31 (18.81) 46.30 (16.08) 46.54 (16.11) 49.03 (16.97)
Median (IQR) 48.80 (27.00) 49.40 (29.30) 44.00 (31.30) 43.90 (23.70) 44.30 (24.05) 47.70 (27.20)
<40 3166 31.64 339 32.56 251 44.11 610 40.48 642 39.63 925 34.84
40- 2046 20.45 189 18.16 87 15.29 317 21.04 342 21.11 526 19.81
50- 1796 17.95 165 15.85 74 13.01 242 16.06 270 16.67 439 16.53
60 2993 29.92 348 33.43 157 27.59 338 22.43 366 22.59 765 28.81
Missing 4 0.04
H. pylori IgG
Negative 6924 69.21 711 68.30 418 73.46 1125 74.65 1201 74.14 1854 30.17
Positive 3081 30.79 330 31.70 151 26.54 382 25.35 419 25.86 801 69.83
Body mass index
Mean (SD) 26.36 (4.06) 27.19 (4.51) 27.01 (4.40) 26.32 (4.15) 26.39 (4.15) 26.76 (4.31)
Median (IQR) 25.80 (5.00) 26.50 (6.00) 26.45 (6.10) 25.80 (5.10) 25.90 (5.20) 26.20 (5.40)
<20 273 2.73 22 2.13 14 2.47 41 2.73 44 2.73 64 2.42
20- 3666 36.64 313 30.24 177 31.27 560 37.31 594 36.80 887 33.57
25- 4362 43.60 440 42.51 237 41.87 651 43.37 701 43.43 1149 43.49
30 1656 16.55 260 25.12 138 24.38 249 16.59 275 17.04 542 20.51
Missing 48 0.48
Waist circumference (cm)
Mean (SD) 86.56 (11.86) 89.25 (12.95) 87.71 (12.47) 85.85 (12.10) 86.00 (12.10) 87.64 (12.56)
Median (IQR) 86.00 (16.00) 89.00 (18.00) 87.00 (18.00) 85.00 (16.00) 86.00 (16.00) 87.00 (18.00)
Women<75; Men<88 3095 30.93 253 24.56 156 27.76 474 31.83 499 31.17 739 28.14
75  Women <86; 88  Men<96 3493 34.91 315 30.58 180 32.03 535 35.93 575 35.92 885 33.70
Women86; Men96 3303 33.01 462 44.85 226 40.21 480 32.24 527 32.92 1002 38.16
Missing 114 1.14
Tobacco smoking
No smoking 4112 41.10 380 36.50 380 66.78 703 46.65 742 45.80 1048 39.47
Smoking occasionally 3057 30.55 355 34.10 140 24.60 452 29.99 488 30.12 822 30.96
Smoking daily 2831 28.30 306 29.39 49 8.61 352 23.36 390 24.07 785 29.57
Missing 5 0.05
Alcohol drinking
Never 2373 23.72 276 26.51 145 25.48 379 25.15 400 24.69 664 25.01
Infrequent 4572 45.70 454 43.61 259 45.52 724 48.04 776 47.90 1211 45.61
Frequent 1399 13.98 140 13.45 58 10.19 208 13.80 226 13.95 361 13.60
Missing 1661 16.60
Physical activity
Inactive 1709 17.08 195 18.73 83 14.59 224 14.86 249 15.37 464 17.48
Moderately active 2954 29.53 299 28.72 165 29.00 503 33.38 533 32.90 822 30.96
Highly active 4234 42.32 428 41.11 257 45.17 678 44.99 723 44.63 1111 41.85
Missing 1108 11.07
Education
Primary school 3241 32.39 363 34.87 158 27.77 417 27.67 450 27.78 859 32.35
High school 3191 31.89 322 30.93 169 29.70 457 30.33 500 30.86 829 31.22
College/university 3095 30.93 297 28.53 209 36.73 581 38.55 610 37.65 838 31.56
Missing 478 4.78
Family history of asthma
No 7963 79.59 636 61.10 299 52.55 599 39.75 1026 63.33 1805 67.98
Yes 2038 20.37 405 38.90 270 47.45 908 60.25 594 36.67 850 32.02
Missing 4 0.04
Family history of allergic rhinitis
No 6927 69.24 577 55.43 347 60.98 945 62.71 670 41.36 1411 53.15
Yes 3074 30.72 464 44.57 222 39.02 562 37.29 950 58.64 1244 46.85
Missing 4 0.04
Asthma deﬁnition I: Asthma or medication for asthma.
Asthma deﬁnition II: Deﬁnition I, excluding those smoking for more than 10 years.
Allergic rhinitis: Hay fever or nasal allergies or use of anti-allergy medications.
SD: standard deviation.
IQR: interquartile range.
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fever or nasal allergies (fully adjusted OR 0.75, 95% CI 0.59–0.95).
Discussion
In the present study we found no association between H. pylori
infection and asthma or allergic diseases in general. However, H. pylori3infection was associated with a reduced risk of asthma and allergy in
individuals with abdominal obesity, suggesting a possible causal
pathway from reduced H. pylori infections through obesity to increased
asthma and allergy.
The strengths of this study include the population-based design, large
sample size, and random selection of participants where H. pylori status
was assessed, reducing the risk of selection bias and chance ﬁndings. In
Table 2
Odds ratios (ORs) and 95% conﬁdence intervals (CIs) of H. pylori infection relative to asthma and allergy.
H. pylori infection
Negative Positive dBasic model eFull model
N N OR (95% CI) OR (95% CI)
aAsthma (deﬁnition I) 711 330 1.01 (0.87,1.17) 1.00 (0.86,1.17)
Asthma (onset at age<18) 287 82 0.92 (0.70,1.20) 0.93 (0.71,1.22)
Asthma (onset at age18) 228 141 1.07 (0.85,1.34) 1.08 (0.85,1.36)
bAsthma (deﬁnition II) 418 151 0.90 (0.73,1.11) 0.94 (0.76,1.16)
Hay fever or nasal allergies 1125 382 0.91 (0.79,1.04) 0.93 (0.81,1.07)
cAllergic rhinitis 1201 419 0.93 (0.81,1.06) 0.95 (0.83,1.09)
Asthma or allergic rhinitis 1854 801 1.02 (0.92,1.13) 1.03 (0.92,1.14)
a Asthma deﬁnition I: Asthma or medication for asthma.
b Asthma deﬁnition II: Deﬁnition I, excluding those smoking for more than 10 years.
c Allergic rhinitis: Hay fever or nasal allergies or use of anti-allergy medications.
d Basic model: Adjusted for sex and age.
e Full model: Adjusted for sex, age, body mass index, tobacco smoking, alcohol drinking, physical activity, education, and family history of asthma or allergic rhinitis.
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that made adjustments for important confounders possible. The objective
measurements of BMI and waist circumference are of great importance
when assessing obesity. One weakness in this study is the self-reported
asthma and allergy. This might introduce misclassiﬁcation, mainly to-
wards COPD. This is partly avoided by using a deﬁnition of asthma
excluding participants that had smoked for more than 10 years (deﬁni-
tion II) and stratiﬁed asthma with onset below 18 years of age (childhood
asthma). Another weakness is the lack of data on cagA status, which has
been regarded as an important factor in H. pylori infection that is nega-
tively associated with asthma and allergy.19 As this is an observational
study, causal associations cannot be claimed based on concurrent mea-
surements of outcomes, exposures, and confounders.
A potential inverse relationship between H. pylori and asthma and
allergy has been widely reported, although the results are con-
troversial.20–25 In the largest meta-analysis including 19 studies,9 an in-
verse association between H. pylori and asthma was demonstrated based
on nine cross-sectional studies (pooled OR 0.84, 95% CI 0.74–0.96), but
the pooled OR was not statistically signiﬁcant in seven case-control
studies (pooled OR 0.82, 95% CI 0.53–1.27) or three prospective
cohort studies (pooled OR 0.82, 95% CI 0.53–1.27). Interestingly, the
meta-analysis showed an inverse association in children (pooled OR 0.81,
95% CI 0.72–0.91) but not in adults (pooled OR 0.88, 95% CI 0.71–1.08),
which is partially consistent with our results. The beneﬁt of H. pylori in
early life has been observed in quite a few studies,20–22,26,27 but at a
late-in-life cost (e.g., H. pylori is a risk factor of peptic ulcer disease and
stomach cancer).28 However, in the present study, such an inverse as-
sociation were only identiﬁed in abdominally obese persons who had
asthma or allergic rhinitis in their early life. This result may indicate an
intriguing and complex relationship between H. pylori, obesity, and
asthma and allergy.
A possible inverse relationship between exposure to H. pylori and the
occurrence of obesity has been addressed as well,15,29–31 although the
results are still controversial.32 Moreover, whether H. pylori infection
plays a role only in childhood or adult adiposity is unclear. As both
H. pylori and obesity have been associated with asthma and allergic
disease, the role of the two factors needs to be further clariﬁed. Whether
one factor is another factor's confounder, effect modiﬁer or intermediate
is unknown. In the present study, there was an association between
H. pylori and asthma and allergic disease in abdominally obese partici-
pants, but this association disappeared in the non-abdominally obese
population. This indicates that obesity may play a role as an effect
modiﬁer between H. pylori and asthma and allergy. As the analyses were
based on cross-sectional data, potential obesity could be an intermediate
in the pathway from H. pylori to asthma and allergy.
The underlying mechanisms between H. pylori, obesity, and asthma
and allergy are plausible. H. pylori are one of the most common bacteria
in humans, with prevalence rates of H. pylori in human populations4ranging from 20 to 50%.33,34 In the past decades, infection with
H. pylori substantially declined due to improved living conditions and
increased use of antibiotics. Individuals exposed to H. pylori in early
childhood are prone to have a decreased appetite and food intake due to
defective signalling of appetite- and satiety-related hormones in the
stomach, e.g., ghrelin and leptin.20,35 Hormone ghrelin exerts
long-term appetite stimulating behaviour through its receptors in the
hypothalamic paraventricular and arcuate nuclei.36,37 Decreased
exposure to H. pylori results in increased ghrelin and downregulated
gastric leptin in children and in adults, thus increasing appetite stim-
ulating behaviour and then leading to obesity. Interestingly, ghrelin has
been associated with abdominal adiposity through regulation of lipid
storage in abdominal white adipose tissue38; higher leptin levels has
also been associated with abdominal obesity in quite a few studies.39,40
In addition, H. pylori could be an indicator for changes in the gut
microbiome. It reﬂects the complex interaction between microbes and
the immune system.41,42 When H. pylori are eradicated (other microbes
will be inﬂuenced as well), the inner balance of microbes,
appetite-related hormones, and the immune system will be broken, and
then the person will become obese. The cytokines stimulated by chronic
inﬂammation in the obese population will further trigger asthma and
allergy. On the other hand, in obese persons, the cytokines may be
supressed by infection with H. pylori. A protective association of
H. pylori with asthma and allergic disease through obesity is plausible.
This hypothesis aligns with the present study.
Another potential pathway is through Th1 and Th2 lymphocytes. A
growing body of evidence indicates a preventive action of H. pylori to
asthma and allergy probably through the gastric recruitment of regula-
tory T cells.43 It is well recognized that infections with H. pylori can
trigger a Th1-mediated immune response.43 Activation of Th1 then
suppresses the Th2 responses. The predominant activation of Th1 lym-
phocytes by H. pylori leads to the production of interferon gamma,
interleukin 12, and tumor necrosis factor alpha in the stomach.44 Erad-
ication of H. pyloriwill lead to inadequate Th1 response that might result
in an overactive Th2 response with production of cytokines, including
interleukins 4, 5, and 13, which are associated with the promotion of IgE
and eosinophilic responses, and eventually allergies. The inverse asso-
ciation between H. pylori and asthma and allergic disease was ﬁrst
observed in 1989 with the “hygiene hypothesis”.45 It was based on ob-
servations of declining prevalence of allergic rhinitis with increasing
number of older siblings. It suggested a preventive effect of transmitted
infections in early childhood from older siblings. Exposure to infectious
agents might educate the immune system and provide protection against
allergic rhinitis. However, how obesity plays a role in this pathway is
unclear. As the beneﬁt of H. pylori was only shown in the obese popu-
lation, the present study might suggest that the immune system educated
by infection with H. pylori may be more alert to asthma and allergy in
those obese.
Table 3
Odds ratios (ORs) and 95% conﬁdence intervals (CIs) of H. pylori infection relative to asthma and allergy, stratiﬁed by waist circumference.
Waist circumference (cm): women<75; men<88 Waist circumference (cm): 75  women<86; 88  men<96 Waist circumference (cm): women86; men96
H. pylori infection H. pylori infection H. pylori infection
Negative Positive Basic modeld Full Model Negative Positive Basic modeld Full Model Negative Positive Basic modeld Full Model
N N OR (95%CI) OR (95%CI) N N OR (95%CI) OR (95%CI) N N OR (95%CI) OR (95%CI)
Asthma (deﬁnition I)a 193 60 0.97 (0.70,1.34) 0.93 (0.67,1.30) 213 102 1.16 (0.90,1.52) 1.17 (0.89,1.53) 297 165 0.91 (0.73,1.14) 0.92 (0.73,1,15)
Asthma (onset at age<18) 102 24 0.97 (0.60,1.57) 0.97 (0.59,1.59) 87 31 1.19 (0.77,1.85) 1.24 (0.77,1.94) 90 24 0.58 (0.36,0.93)* 0.61 (0.37,0.99)*
Asthma (onset at age18) 37 25 1.55 (0.89,2.70) 1.46 (0.83,2.57) 67 36 1.02 (0.66,1.57) 1.00 (0.64,1.55) 119 80 0.99 (0.73,1.35) 0.98 (0.71,1.35)
Asthma (deﬁnition II)b 125 31 1.00 (0.65,1.54) 1.05 (0.67,1.63) 127 53 1.12 (0.79,1.59) 1.23 (0.85,1.77) 161 65 0.69 (0.50,0.94)* 0.70 (0.50,0.97)*
Hay fever or nasal allergies 378 96 0.97 (0.75,1.27) 0.98 (0.74,1.29) 388 147 1.07 (0.86,1.33) 1.09 (0.86,1.37) 346 134 0.72 (0.57,0.91)* 0.75 (0.59,0.95)*
Allergic rhinitisc 399 100 0.96 (0.74,1.25) 0.97 (0.74,1.27) 417 158 1.06 (0.85,1.31) 1.07 (0.86,1.34) 372 155 0.77 (0.62,0.96)* 0.80 (0.64,1.01)
Asthma or allergic rhinitis 571 168 0.99 (0.80,1.223) 0.99 (0.79,1.23) 617 268 1.09 (0.91,1.30) 1.10 (0.92,1.32) 644 358 0.96 (0.81,1.13) 0.98 (0.83, 1.16)
a Asthma deﬁnition I: Asthma or medication for asthma.
b Asthma deﬁnition II: Deﬁnition I, excluding those smoking for more than 10 years.
c Allergic rhinitis: Hay fever or nasal allergies or use of anti-allergy medications.
d Basic model: Adjusted for sex and age.
* p < 0.05.
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E. Ness-Jensen et al. World Allergy Organization Journal 12 (2019) 100035In conclusion, this large population-based study found reduced risk of
asthma and allergy with H. pylori infection in individuals with abdominal
obesity. This suggests a possible protective effect ofH. pylori infection in the
development of asthma and allergy and possibly a causal pathway from
reducedH.pylori infections throughobesity to increasedasthmaandallergy.
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